Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1

First line targeted therapies in breast cancer: focus on bevacizumab || FREE PAPER ||

       
Total article views   HTML views PDF downloads Totals
7,339 Dovepress* 7,339+ 1,968 9,307
Totals 7,339 1,968 9,307
*Since 15 August 2007
+Since July 2016

View citations on Google Scholar